iSERA Lifesciences Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 18, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	965	464	219	22	0	12
Market Cap Growth	236361.09%	111.95%	917.05%	4951.17%	-96.41%	72.31%
Enterprise Value	953	480	221	23	0	31
Last Close Price	114.73	55.16	676.67	676.67	473.33	373.33
PE Ratio	371.92	178.81	157.45	-	-	-
PS Ratio	70.50	33.89	82.52	-	-	-
PB Ratio	11.70	5.62	-223.31	-9.95	-0.37	-263.13
P/TBV Ratio	11.70	5.62	-	-	-	-
EV/Sales Ratio	69.62	35.07	83.50	-	-	-
EV/EBIT Ratio	-	171.57	159.30	-	-	-
Debt / Equity Ratio	0.20	0.20	-16.38	-0.85	-1.08	-
Net Debt / Equity Ratio	-0.15	-0.15	-16.17	-0.85	-1.05	0.22
Net Debt / EBITDA Ratio	-	-	-	-	-	0.15
Net Debt / FCF Ratio	0.23	0.23	-1.13	-3.01	-0.99	0.00
Asset Turnover	0.23	0.23	0.33	-	-	-
Quick Ratio	6.32	6.32	7.22	0.02	0.07	0.18
Current Ratio	6.63	6.63	33.63	0.63	1.21	0.18
Return on Equity (ROE)	6.37%	6.37%	-	-	-	-
Return on Assets (ROA)	2.89%	2.89%	10.80%	-117.20%	-282.13%	-2.93%
Return on Invested Capital (ROIC)	5.05%	5.06%	19.13%	-	-185.14%	-27.12%
Return on Capital Employed (ROCE)	2.80%	2.80%	9.20%	311.70%	-1314.70%	2338.30%
Earnings Yield	0.27%	0.56%	0.64%	-4.38%	-262.36%	-8.89%
FCF Yield	-	-11.54%	-6.40%	-2.82%	-289.57%	-25.27%
Buyback Yield / Dilution	-2525.54%	-2525.54%	-6.76%	-0.09%	-	-